These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16478831)

  • 1. Modulation of cardiovascular risk factors by obstructive sleep apnea.
    Olson LJ; Somers VK
    Chest; 2006 Feb; 129(2):218-220. PubMed ID: 16478831
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.
    Steiropoulos P; Tsara V; Nena E; Fitili C; Kataropoulou M; Froudarakis M; Christaki P; Bouros D
    Chest; 2007 Sep; 132(3):843-51. PubMed ID: 17573492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnea hypopnea syndrome: a proinflammatory disorder.
    Han F
    Chin Med J (Engl); 2007 Sep; 120(17):1475-6. PubMed ID: 17908451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beneficial effect of continuous positive airway pressure therapy in obstructive sleep apnea syndrome].
    Magyar MT
    Orv Hetil; 2014 Nov; 155(47):1855-9. PubMed ID: 25403278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome].
    Rubinsztajn R; Kumor M; Byśkiniewicz K; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):63-7. PubMed ID: 17175979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cardiovascular risk factors in obstructive sleep apnea.
    Can M; Açikgöz Ş; Mungan G; Bayraktaroğlu T; Koçak E; Güven B; Demirtas S
    Chest; 2006 Feb; 129(2):233-237. PubMed ID: 16478836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome.
    Jordan W; Berger C; Cohrs S; Rodenbeck A; Mayer G; Niedmann PD; von Ahsen N; Rüther E; Kornhuber J; Bleich S
    J Neural Transm (Vienna); 2004 Jun; 111(6):683-9. PubMed ID: 15168215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea with Cardiovascular Disease.
    Van Ryswyk E; Anderson CS; Barbe F; Loffler KA; Lorenzi-Filho G; Luo Y; Quan W; Wang J; Zheng D; McEvoy RD
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1433-1435. PubMed ID: 30849229
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular morbidity and obstructive sleep apnea.
    Basner RC
    N Engl J Med; 2014 Jun; 370(24):2339-41. PubMed ID: 24918377
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome.
    Kokturk O; Ciftci TU; Mollarecep E; Ciftci B
    Respir Med; 2006 Mar; 100(3):536-41. PubMed ID: 16024243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sleep apnea as a risk factor. Nightmare for the cardiovascular system].
    MMW Fortschr Med; 2004 Apr; 146(18):6, 8. PubMed ID: 15366458
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea.
    Kasai T; Inoue K; Kumagai T; Kato M; Kawana F; Sagara M; Ishiwata S; Ohno M; Yamaguchi T; Momomura S; Narui K
    Am J Hypertens; 2011 Apr; 24(4):401-7. PubMed ID: 21193850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Continuous Positive Airway Pressure on Cardiovascular Risk Factors in High-Risk Patients.
    Zhao YY; Redline S
    Curr Atheroscler Rep; 2015 Nov; 17(11):62. PubMed ID: 26370408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing continuous positive airway pressure therapy for obstructive sleep apnea syndrome.
    McNicholas WT
    Sleep; 2006 Apr; 29(4):421-3. PubMed ID: 16676772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Homocysteine levels in patients with obstructive sleep apnea syndrome].
    Yavuz Z; Ursavaş A; Ege E; Ozarda Ilçol Y; Karadağ M; Uzaslan E; Gözü RO
    Tuberk Toraks; 2008; 56(1):37-42. PubMed ID: 18330753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of Obstructive Sleep Apnea: Cardiovascular Risk of Obstructive Sleep Apnea and Whether Continuous Positive Airway Pressure Reduces that Risk.
    Khayat R; Pleister A
    Sleep Med Clin; 2016 Sep; 11(3):273-86. PubMed ID: 27542874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of continuous positive airway pressure therapy in reducing cardiovascular events in obstructive sleep apnea: a systematic review.
    Parsons C; Allen S; Parish J; Mookadam F; Mookadam M
    Future Cardiol; 2017 Jul; 13(4):397-412. PubMed ID: 28631492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome.
    Akashiba T; Akahoshi T; Kawahara S; Majima T; Horie T
    Intern Med; 2005 Aug; 44(8):899-900. PubMed ID: 16157997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea.
    Marinheiro R; Parreira L; Amador P; Mesquita D; Farinha J; Fonseca M; Duarte T; Lopes C; Fernandes A; Caria R
    Curr Cardiol Rev; 2019; 15(1):64-74. PubMed ID: 30338742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment.
    Finucane TE
    Ann Intern Med; 2012 Jun; 156(11):838; author reply 838. PubMed ID: 22665819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.